STOCK-BASED COMPENSATION (Tables)
|
9 Months Ended |
12 Months Ended |
Sep. 30, 2021 |
Dec. 31, 2020 |
| Share-based Payment Arrangement [Abstract] |
|
|
| Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions |
The
following table provides the weighted average assumptions used in determining the fair value of the stock option awards granted during
the nine-month periods ended September 30, 2021 and 2020.
SCHEDULE OF FAIR VALUE ASSUMPTIONS OF STOCK OPTIONS
| |
|
September
30, 2021 |
|
|
September
30, 2020 |
|
| |
|
(unaudited) |
|
| Risk-free interest
rate |
|
|
0.78 |
% |
|
|
0.79 |
% |
| Expected life |
|
|
6.0
years |
|
|
|
6.6
years |
|
| Expected volatility |
|
|
134.79 |
% |
|
|
122.24 |
% |
| Dividend yield |
|
|
- |
|
|
|
- |
|
|
The
following table provides the weighted average assumptions used in determining the fair value of the stock options granted during
the years ended December 31, 2020 and December 31, 2019.
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions
| |
|
December
31, 2020 |
|
|
December
31, 2019 |
|
| Risk-free interest rate |
|
|
0.75 |
% |
|
|
2.34 |
% |
| Expected life |
|
|
6.5
years |
|
|
|
5.9
years |
|
| Expected volatility |
|
|
123.71 |
% |
|
|
128.58 |
% |
| Dividend yield |
|
|
- |
|
|
|
- |
|
|
| SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE |
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE
| |
|
Three Months Ended |
|
|
Nine Months Ended |
|
| |
|
September
30, |
|
|
September
30, |
|
| |
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
| |
|
(unaudited) |
|
|
(unaudited) |
|
| Cost of revenue |
|
$ |
52 |
|
|
$ |
60 |
|
|
$ |
154 |
|
|
$ |
187 |
|
| Sales and marketing |
|
|
76 |
|
|
|
39 |
|
|
|
201 |
|
|
|
136 |
|
| Research and development |
|
|
24 |
|
|
|
30 |
|
|
|
83 |
|
|
|
99 |
|
| General
and administrative* |
|
|
325 |
|
|
|
434 |
|
|
|
876 |
|
|
|
959 |
|
| Total
stock compensation expense |
|
$ |
477 |
|
|
$ |
563 |
|
|
$ |
1,314 |
|
|
$ |
1,381 |
|
|
|
| Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award |
|
Stock-based
compensation for the years ended December 31, 2020 and 2019
is as follows:
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award
| |
|
2020 |
|
|
2019 |
|
| RSUs and restricted stock |
|
$ |
176 |
|
|
$ |
243 |
|
| Performance-based awards |
|
|
265 |
|
|
|
- |
|
| Common stock awards |
|
|
116 |
|
|
|
- |
|
| Options |
|
|
1,630 |
|
|
|
722 |
|
| Total stock-based
compensation expense |
|
$ |
2,187 |
|
|
$ |
965 |
|
|
| Schedule of Stock Option Activity |
|
A
summary of stock option and SARs activity for the year ended December 31, 2020, and changes during such year, is presented below:
Schedule of Stock Option Activity
| |
|
|
|
|
Weighted- |
|
|
Weighted-Average |
|
|
|
|
| |
|
|
|
|
Average |
|
|
Remaining |
|
|
Aggregate |
|
| |
|
|
|
|
Grant |
|
|
Contractual |
|
|
Intrinsic |
|
| |
|
Shares |
|
|
Price |
|
|
Period
(in years) |
|
|
Value |
|
| Outstanding at January 1, 2020 |
|
|
415,678 |
|
|
$ |
12.50 |
|
|
|
8.45 |
|
|
$ |
- |
|
| Granted |
|
|
525,550 |
|
|
|
6.24 |
|
|
|
9.39 |
|
|
|
- |
|
| Exercised |
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Forfeited or
expired |
|
|
(92,409 |
) |
|
|
11.18 |
|
|
|
|
|
|
|
- |
|
| Outstanding at December 31, 2020 |
|
|
848,819 |
|
|
|
8.76 |
|
|
|
8.59 |
|
|
|
- |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercisable at December 31, 2020 |
|
|
361,501 |
|
|
|
11.81 |
|
|
|
7.77 |
|
|
|
- |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Vested and expected to vest |
|
|
659,465 |
|
|
|
9.48 |
|
|
|
8.39 |
|
|
|
- |
|
|
| Schedule of Non Vested Option Activity |
|
A
summary of the status of the Company’s non-vested options for the year ended December 31, 2020, and changes during such
year, is presented below:
Schedule of Non Vested Option Activity
| |
|
Shares |
|
|
Weighted-
Average Grant Date Fair Value |
|
| |
|
|
|
|
|
|
| Nonvested at January 1, 2020 |
|
|
213,472 |
|
|
$ |
8.80 |
|
| Granted |
|
|
525,550 |
|
|
|
5.36 |
|
| Vested |
|
|
(197,998 |
) |
|
|
7.34 |
|
| Forfeited |
|
|
(53,706 |
) |
|
|
7.86 |
|
| Nonvested at December 31, 2020 |
|
|
487,318 |
|
|
$ |
5.81 |
|
|
| Schedule of Share-Based Compensation, Restricted Stock and Restricted Stock Units Activity |
|
A
summary of the Company’s non-vested shares of restricted stock and restricted stock units for the year ended December 31,
2020, and changes during such year, is presented below:
Schedule of Share-Based Compensation, Restricted Stock and Restricted Stock Units Activity
| |
|
|
|
|
Weighted- |
|
|
Average |
|
|
|
|
| |
|
|
|
|
Average |
|
|
Remaining |
|
|
Aggregate |
|
| |
|
|
|
|
Grant Date |
|
|
Vesting |
|
|
Intrinsic |
|
| |
|
Shares |
|
|
Fair
Value |
|
|
Period
(in years) |
|
|
Value |
|
| Nonvested at January 1, 2020 |
|
|
49,366 |
|
|
$ |
10.04 |
|
|
|
1.11 |
|
|
$ |
246,830 |
|
| Granted |
|
|
236,321 |
|
|
|
3.43 |
|
|
|
- |
|
|
|
- |
|
| Vested |
|
|
(43,976 |
) |
|
|
9.52 |
|
|
|
- |
|
|
|
- |
|
| Forfeited |
|
|
(2,254 |
) |
|
|
10.10 |
|
|
|
- |
|
|
|
- |
|
| Nonvested at December 31, 2020 |
|
|
239,457 |
|
|
$ |
3.61 |
|
|
|
1.75 |
|
|
$ |
751,895 |
|
|